Mitochondrial disorders leading to Alzheimer’s disease—perspectives of diagnosis and treatment

Magdalena Pszczołowska,Kamil Walczak,Weronika Miśków,Magdalena Mroziak,Justyna Chojdak-Łukasiewicz,Jerzy Leszek

DOI: https://doi.org/10.1007/s11357-024-01118-y

2024-03-08

GeroScience

Abstract:Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common cause of dementia globally. The pathogenesis of AD remains still unclear. The three main features of AD are extracellular deposits of amyloid beta (Aβ) plaque, accumulation of abnormal formation hyper-phosphorylated tau protein, and neuronal loss. Mitochondrial impairment plays an important role in the pathogenesis of AD. There are problems with decreased activity of multiple complexes, disturbed mitochondrial fusion, and fission or formation of reactive oxygen species (ROS). Moreover, mitochondrial transport is impaired in AD. Mouse models in many research show disruptions in anterograde and retrograde transport. Both mitochondrial transportation and network impairment have a huge impact on synapse loss and, as a result, cognitive impairment. One of the very serious problems in AD is also disruption of insulin signaling which impairs mitochondrial Aβ removal. Discovering precise mechanisms leading to AD enables us to find new treatment possibilities. Recent studies indicate the positive influence of metformin or antioxidants such as MitoQ, SS-31, SkQ, MitoApo, MitoTEMPO, and MitoVitE on mitochondrial functioning and hence prevent cognitive decline. Impairments in mitochondrial fission may be treated with mitochondrial division inhibitor-1 or ceramide. Graphical Abstract (Graphic content via Canva Pro)

geriatrics & gerontology,gerontology

What problem does this paper attempt to address?

The paper attempts to address the issue of exploring the role of mitochondrial dysfunction in Alzheimer's disease (AD) and proposes new perspectives for diagnosis and treatment.

Specifically, the paper focuses on the following aspects:
1. **The relationship between mitochondrial dysfunction and AD**: The paper describes in detail how mitochondrial dysfunction affects the pathological process of AD, including aspects such as energy metabolism, oxidative stress, and protein accumulation.
2. **Specific mechanisms of mitochondrial dysfunction**: The paper discusses specific mechanisms such as decreased activity of mitochondrial complexes, dysregulation of mitochondrial fusion and fission, and increased generation of reactive oxygen species (ROS).
3. **Impaired mitochondrial transport and network**: The paper points out the impact of impaired mitochondrial transport and network dysfunction on synaptic loss and cognitive decline.
4. **Antioxidants and drug treatments**: The paper explores the improvement of mitochondrial function by various antioxidants and drugs (such as metformin, MitoQ, SS-31, SkQ, MitoApo, MitoTEMPO, MitoVitE, etc.) and their potential applications in AD treatment.
5. **Lifestyle adjustments**: The paper also mentions the potential benefits of lifestyle changes (such as diet and physical activity) for the prevention and treatment of AD.

Through these studies, the paper aims to provide new ideas and methods for the diagnosis and treatment of AD.